C

Cohance Lifesciences Ltd

PharmaceuticalsSmallcap

About the company

Cohance Lifesciences Limited is a technology-driven CDMO in India, offering custom synthesis, process R&D, and manufacturing services for pharmaceuticals and specialty chemicals.

Performance

Stock
Loading Stock value
—

Analyst Ratings and Key Metrics

Based on 7 analysts offering recommendations for Cohance Lifesciences Ltd

57%

Buy

14%

Hold

29%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio96.3445.78
PB Ratio4.285.74
Dividend Yield—0.50%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions